½ÃÀ庸°í¼­
»óǰÄÚµå
1421668

Ç÷¾×Çü °Ë»ç ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : °Ë»ç À¯Çüº°, Á¦Ç° À¯Çüº°, ±â¼úº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)

Blood Group Typing Market Share, Size, Trends, Industry Analysis Report, By Test Type (HLA Typing, ABO Blood Test, Antibody Screening, Cross-matching Tests, Antigen Typing); By Product Type; By Technique; By Region; Segment Forecast, 2024- 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 116 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, 2032³â±îÁö Ç÷¾×Çü °Ë»ç ºÐ¼® ¼¼°è ½ÃÀå ±Ô¸ð´Â 45¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

Ç÷¾×ÇüÀº Ç÷¾×À» A, B, AB, AB, OÀÇ 4°¡Áö À¯ÇüÀ¸·Î ºÐ·ùÇϰí Rh ÀÎÀÚÀÇ À¯¹«¸¦ È®ÀÎÇÏ´Â Áß¿äÇÑ °Ë»ç ÀýÂ÷ÀÔ´Ï´Ù. ÀÌ °Ë»ç´Â ¾ÈÀüÇÑ ¼öÇ÷°ú ÇåÇ÷ÀÚ¿Í ¼öÇ÷ÀÚ °£ÀÇ ÀûÇÕ¼ºÀ» ÆÇ´ÜÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

Ç÷¾×Çü °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀº »ç°í, ÀÀ±Þ »óȲ, ¿Ü»ó À¯º´·ü Áõ°¡, »êÀü °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. Á¶±â °ËÁø, ¾ÈÀüÇÑ ¼öÇ÷, ¹ýÀÇÇÐ ºÐ¾ß¿¡¼­ÀÇ Ã¤ÅÃÀº ½ÃÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ±×·¯³ª Á¦ÇÑµÈ ÀνÄ, ºÒÃæºÐÇÑ ÀÇ·á ÀÎÇÁ¶ó, ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·°ú °°Àº ¹®Á¦´Â Ç÷¾× ÀºÇà ½Ã¾àÀÇ ÆÇ¸Å¸¦ ¹æÇØÇϰí ÀáÀçÀûÀ¸·Î ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

2021³â ¼¼°èº¸°Ç±â±¸(WHO)´Â ºóÇ÷ À¯º´·üÀ» ¼Ò¾Æ 48.2%, ³²¼º 12.8%·Î º¸°íÇÏ¿© Àü ¼¼°èÀûÀ¸·Î Ç÷¾× ÁúȯÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Ç÷¾×ÀÌ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ ½Ã»çÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó Ç÷¾×Çü °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ç÷¾×Çü °Ë»ç ½ÃÀåÀº Çö´ë ÀÇ·á¿¡ Å« ±âȸ¸¦ °¡Á®´ÙÁÖ°í ÀÖ½À´Ï´Ù. »ç°í, ¼ö¼ú, ¸¸¼ºÁúȯ Áõ°¡·Î ÀÎÇØ ¼öÇ÷¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. PCR°ú NGS¿Í °°Àº ºÐÀÚ ±â¼úÀÇ ¹ßÀüÀ¸·Î Ç÷¾×Çü ºÐ·ùÀÇ Á¤È®µµ°¡ Çõ½ÅÀûÀ¸·Î Çâ»óµÇ°í ÀÖÀ¸¸ç, Ç÷¾×Çü¿¡ µû¸¥ °³Àκ° ¸ÂÃã Ä¡·á°¡ ±Þ°ÝÇÏ°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °³Àκ° Ç÷¾×Çü¿¡ ¸Â´Â Ä¡·á¸¦ ÇÏ´Â ¸ÂÃãÀÇ·á´Â ±Þ¼ºÀåÇϰí ÀÖ´Â ºÐ¾ßÀÔ´Ï´Ù. »êÀü °Ë»ç ¹× ¹ýÀÇÇÐ ºÐ¾ß¿¡µµ Ç÷¾×Çü ºÐ·ùÀÇ Àû¿ëÀÌ È®´ëµÇ°í ÀÖ¾î »õ·Î¿î ¼ºÀåÀÇ ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÊ¿¡ µû¶ó Á¤¹ÐÇÑ Ç÷¾×Çü ºÐ¼® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â Ç÷¾×Çü °Ë»ç ½ÃÀåÀÇ À¯¸ÁÇÑ Àü¸ÁÀ» º¸¿©ÁÝ´Ï´Ù.

Ç÷¾×Çü °Ë»ç ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ¿Ü°ú ¼ö¼ú Áõ°¡·Î ÀÎÇØ ¼Ò¸ðǰ ºÎ¹®ÀÌ 2022³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀÔ´Ï´Ù.
  • ABO Ç÷¾×Çü °Ë»ç ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • 2022³â ½ÃÀå ¸ÅÃâ Á¡À¯À²Àº ºÐ¼® ±â¹Ý ¹æ¹ýÀÌ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÈ´Ù,
  • ºÏ¹Ì°¡ 2022³â ½ÃÀå ´ëºÎºÐÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ±× ÀÌÀ¯´Â ±â¼úÀÇ ºñ¾àÀûÀÎ ¼ºÀå°ú ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿¡ ±âÀÎÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ Ç÷¾×Çü °Ë»ç ½ÃÀ庰 ÅëÂû

  • Ç÷¾×Çü °Ë»ç ½ÃÀå - ±â¼ú ÇöȲ
  • Ç÷¾×Çü °Ë»ç ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • PESTEL ºÐ¼®
  • Ç÷¾×Çü °Ë»ç ½ÃÀå ±â¼ú µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ Ç÷¾×Çü °Ë»ç ½ÃÀå, °Ë»ç À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • HLA ŸÀÌÇÎ
  • ABO Ç÷¾×Çü
  • Ç×ü ½ºÅ©¸®´×
  • Å©·Î½º ¸ÅĪ Å×½ºÆ®
  • Ç׿ø °Ë»ç

Á¦6Àå ¼¼°èÀÇ Ç÷¾×Çü °Ë»ç ½ÃÀå, Á¦Ç° À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ÀåÄ¡
  • ¼Ò¸ðǰ
  • ¼­ºñ½º

Á¦7Àå ¼¼°èÀÇ Ç÷¾×Çü °Ë»ç ½ÃÀå, ±â¼úº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ¾î¼¼ÀÌ ±â¹Ý ±â¼ú
  • PCR ±â¹Ý ¹× ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â¼ú
  • Ãʺ´·Ä ½ÃÄö½Ì ±â¼ú
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ Ç÷¾×Çü °Ë»ç ½ÃÀå, Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • Ç÷¾×Çü °Ë»ç ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
  • Ç÷¾×Çü °Ë»ç ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : Ç÷¾×Çü °Ë»ç ½ÃÀå, °Ë»ç À¯Çüº°, 2019-2032³â
    • ºÏ¹Ì : Ç÷¾×Çü °Ë»ç ½ÃÀå, ±â¼úº°, 2019-2032³â
    • ºÏ¹Ì : Ç÷¾×Çü °Ë»ç ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ¹Ì±¹
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ij³ª´Ù
  • Ç÷¾×Çü °Ë»ç ½ÃÀå - À¯·´
    • À¯·´ : Ç÷¾×Çü °Ë»ç ½ÃÀå, °Ë»ç À¯Çüº°, 2019-2032³â
    • À¯·´ : Ç÷¾×Çü °Ë»ç ½ÃÀå, ±â¼úº°, 2019-2032³â
    • À¯·´ : Ç÷¾×Çü °Ë»ç ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ¿µ±¹
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ÇÁ¶û½º
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - µ¶ÀÏ
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ÀÌÅ»¸®¾Æ
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ½ºÆäÀÎ
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ³×´ú¶õµå
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ·¯½Ã¾Æ
  • Ç÷¾×Çü °Ë»ç ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Ç÷¾×Çü °Ë»ç ½ÃÀå, °Ë»ç À¯Çüº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Ç÷¾×Çü °Ë»ç ½ÃÀå, ±â¼úº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Ç÷¾×Çü °Ë»ç ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - Áß±¹
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - Àεµ
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ¸»·¹À̽þÆ
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ÀϺ»
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - Àεµ³×½Ã¾Æ
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - Çѱ¹
  • Ç÷¾×Çü °Ë»ç ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ç÷¾×Çü °Ë»ç ½ÃÀå, °Ë»ç À¯Çüº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ç÷¾×Çü °Ë»ç ½ÃÀå, ±â¼úº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ç÷¾×Çü °Ë»ç ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - À̽º¶ó¿¤
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
  • Ç÷¾×Çü °Ë»ç ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : Ç÷¾×Çü °Ë»ç ½ÃÀå, °Ë»ç À¯Çüº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : Ç÷¾×Çü °Ë»ç ½ÃÀå, ±â¼úº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : Ç÷¾×Çü °Ë»ç ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2032³â
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ¸ß½ÃÄÚ
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ºê¶óÁú
    • Ç÷¾×Çü °Ë»ç ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦9Àå °æÀï ±¸µµ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦10Àå ±â¾÷ °³¿ä

  • Bio-Rad Laboratories, Inc.
  • .BioArray Solutions Ltd.
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Grifols International S.A.
  • Immucor, Inc.(acquired by TPG Capital)
  • Merck KGaA(Merck Millipore)
  • Ortho Clinical Diagnostics, Inc.
  • Quotient Limited
  • Reagen LLC
  • Sekisui Medical Co. Ltd.
  • Thermo Fisher Scientific, Inc.
  • Tulip Diagnostics(Pvt.) Limited
  • Wieslab AB
LSH 24.02.21

The global blood group typing market size is expected to reach USD 4.56 billion by 2032, according to a new study by Polaris Market Research. The report "Blood Group Typing Market Share, Size, Trends, Industry Analysis Report, By Test Type (HLA Typing, ABO Blood Test, Antibody Screening, Cross-matching Tests, Antigen Typing); By Product Type; By Technique; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Blood group typing is a crucial laboratory procedure that classifies blood into four main types - A, B, AB, or O, and identifies the presence of the Rh factor. This test is essential for safe transfusions and determining compatibility between blood donors and recipients.

The growth of the blood group typing market is driven by various factors, including the increasing prevalence of accidents, emergencies, and trauma, as well as the rising demand for prenatal testing. Early screening, safe transfusions, and adoption in forensic sciences further boost the market. However, challenges such as limited awareness, inadequate healthcare infrastructure, and a shortage of skilled professionals can hinder the sales of blood bank reagents, potentially impacting market growth.

In 2021, the World Health Organization reported concerning anemia prevalence rates of 48.2% in children and 12.8% in men, indicating a potential rise in blood disorders worldwide. This trend suggests an increased demand for early diagnosis and treatment, with blood playing a pivotal role. As a result, there will likely be an escalated demand for blood group typing, which is expected to fuel the growth of the market.

The market for blood typing presents a significant opportunity in modern healthcare. The demand for blood transfusions is increasing due to the rising cases of accidents, surgeries, and chronic diseases. Therefore, accurate blood typing is paramount. With advancements in molecular techniques like PCR and NGS, blood typing accuracy is being revolutionized. Personalized medicine, where treatments are tailored to an individual's blood type, is a burgeoning field. The application of blood typing in prenatal testing and forensics is also expanding, offering new avenues for growth. As healthcare infrastructure improves in emerging markets, the demand for precise blood typing technologies is expected to surge. This indicates a promising outlook for the blood typing market.

Blood Group Typing Market Report Highlights

  • The consumables segment accounted for the largest market share in 2022, owing to an increase in surgical procedures
  • The ABO blood test segment is expected to witness the highest growth during the forecast period, due to increasing trauma cases, and accidents
  • Assay-based techniques segment held a significant market revenue share in 2022,
  • North America region dominated the market with a majority share in 2022, owing to exponential growth in the technology and advanced healthcare infrastructure
  • The global key market players include: Bio-Rad Laboratories, Inc., Danaher Corporation, Grifols International S.A, Merck KGaA (Merck Millipore), Ortho Clinical Diagnostics, Inc.

Polaris Market Research has segmented the blood group typing market report based on product type, test type, technique, and region:

Blood Group Typing, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Instruments
  • Consumables
  • Services

Blood Group Typing, Test Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • HLA Typing
  • ABO Blood Test
  • Antibody Screening
  • Cross-matching Tests
  • Antigen Typing

Blood Group Typing, Techniques Outlook (Revenue - USD Billion, 2019 - 2032)

  • Assay-based Techniques
  • PCR-based and Microarray Techniques
  • Massively Parallel Sequencing Techniques
  • Others

Blood Group Typing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Blood Group Typing Market Insights

  • 4.1. Blood Group Typing Market - Technique Snapshot
  • 4.2. Blood Group Typing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise in number of road accidents
      • 4.2.1.2. Increasing demand for blood transfusions
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High costs associated with blood group typing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Blood Group Typing Market Technique Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Blood Group Typing Market, by Test Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
  • 5.3. HLA Typing
    • 5.3.1. Global Blood Group Typing Market, by HLA Typing, by Region, 2019-2032 (USD Billion)
  • 5.4. ABO Blood Test
    • 5.4.1. Global Blood Group Typing Market, by ABO Blood Test, by Region, 2019-2032 (USD Billion)
  • 5.5. Antibody Screening
    • 5.5.1. Global Blood Group Typing Market, by Antibody Screening, by Region, 2019-2032 (USD Billion)
  • 5.6. Cross-matching Tests
    • 5.6.1. Global Blood Group Typing Market, by Cross-matching Tests, by Region, 2019-2032 (USD Billion)
  • 5.7. Antigen Typing
    • 5.7.1. Global Blood Group Typing Market, by Antigen Typing, by Region, 2019-2032 (USD Billion)

6. Global Blood Group Typing Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
  • 6.3. Instruments
    • 6.3.1. Global Blood Group Typing Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.4. Consumables
    • 6.4.1. Global Blood Group Typing Market, by Consumables, by Region, 2019-2032 (USD Billion)
  • 6.5. Services
    • 6.5.1. Global Blood Group Typing Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global Blood Group Typing Market, by Technique

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
  • 7.3. Assay-based Techniques
    • 7.3.1. Global Blood Group Typing Market, by Assay-based Techniques, By Region, 2019-2032 (USD Billion)
  • 7.4. PCR-based and Microarray Techniques
    • 7.4.1. Global Blood Group Typing Market, by PCR-based and Microarray Techniques, By Region, 2019-2032 (USD Billion)
  • 7.5. Massively Parallel Sequencing Techniques
    • 7.5.1. Global Blood Group Typing Market, by Massively Parallel Sequencing Techniques, By Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Blood Group Typing Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Blood Group Typing Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Blood Group Typing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Blood Group Typing Market - North America
    • 8.3.1. North America: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
    • 8.3.3. North America: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.4. Blood Group Typing Market - U.S.
      • 8.3.4.1. U.S.: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.5. Blood Group Typing Market - Canada
      • 8.3.5.1. Canada: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4. Blood Group Typing Market - Europe
    • 8.4.1. Europe: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.4. Blood Group Typing Market - UK
      • 8.4.4.1. UK: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.5. Blood Group Typing Market - France
      • 8.4.5.1. France: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.6. Blood Group Typing Market - Germany
      • 8.4.6.1. Germany: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.7. Blood Group Typing Market - Italy
      • 8.4.7.1. Italy: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.8. Blood Group Typing Market - Spain
      • 8.4.8.1. Spain: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.9. Blood Group Typing Market - Netherlands
      • 8.4.9.1. Netherlands: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.10. Blood Group Typing Market - Russia
      • 8.4.10.1. Russia: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5. Blood Group Typing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.4. Blood Group Typing Market - China
      • 8.5.4.1. China: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.5. Blood Group Typing Market - India
      • 8.5.5.1. India: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.6. Blood Group Typing Market - Malaysia
      • 8.5.6.1. Malaysia: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.7. Blood Group Typing Market - Japan
      • 8.5.7.1. Japan: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.8. Blood Group Typing Market - Indonesia
      • 8.5.8.1. Indonesia: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.9. Blood Group Typing Market - South Korea
      • 8.5.9.1. South Korea: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6. Blood Group Typing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.4. Blood Group Typing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.5. Blood Group Typing Market - UAE
      • 8.6.5.1. UAE: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.6. Blood Group Typing Market - Israel
      • 8.6.6.1. Israel: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.7. Blood Group Typing Market - South Africa
      • 8.6.7.1. South Africa: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
  • 8.7. Blood Group Typing Market - Latin America
    • 8.7.1. Latin America: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.4. Blood Group Typing Market - Mexico
      • 8.7.4.1. Mexico: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.5. Blood Group Typing Market - Brazil
      • 8.7.5.1. Brazil: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.6. Blood Group Typing Market - Argentina
      • 8.7.6.1. Argentina: Blood Group Typing Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Blood Group Typing Market, by Technique, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Blood Group Typing Market, by Product Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bio-Rad Laboratories, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .BioArray Solutions Ltd.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BioMerieux SA
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bio-Rad Laboratories, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Danaher Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Grifols International S.A.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Immucor, Inc. (acquired by TPG Capital)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Merck KGaA (Merck Millipore)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Ortho Clinical Diagnostics, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Quotient Limited
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Reagen LLC
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sekisui Medical Co. Ltd.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Thermo Fisher Scientific, Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Tulip Diagnostics (Pvt.) Limited
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Wieslab AB
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦